Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KW-136 Combined With Sofosbuvir in Adult Chronic Hepatitis C
CTR20171654Phase 3Active
- Sponsor
- Beijing Kawin Technology Share-Holding Co., Ltd.
- Start
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of coblopasvir in hepatitis C virus infection, sponsored by Beijing Kawin Technology Share-Holding Co., Ltd.. Started Jan 2018; status: active.
02
Drugs
coblopasvir
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on CTR20171654.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20171654.